keyword
https://read.qxmd.com/read/34800025/chronic-catheter-related-bacteremia-of-pseudomonas-stutzeri-etiology-as-the-cause-of-membranous-proliferative-glomerulonephritis-mpgn-a-case-report
#21
JOURNAL ARTICLE
Kamil Krzysztof Cołoś, Weronika Lea Śliwińska, Aleksandra Rymarz, Stanisław Niemczyk
UNLABELLED: Secondary membranous - proliferative glomerulonephritis most often develops in the course of viral infections (HCV, HBV), autoimmune diseases, paraproteinemia, and also in the course of chronic bacterial infections. Infections with Pseudomonas stutzeri (P. stutzeri) are extremely rare and usually mildly symptomatic. The natural habitat of this bacterium is soil and water. Nevertheless, in the case of P. stutzeri infection, especially in patients frequently hospitalized or receiving immunosuppressive medications, environmental contamination in healthcare facilities should be taken into account when looking for the source of the infection...
October 22, 2021: Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego
https://read.qxmd.com/read/34445971/paraoxonase-1-gene-pon1-variants-concerning-hepatitis-c-virus-hcv-spontaneous-clearance-in-hemodialysis-individuals-a-case-control-study
#22
JOURNAL ARTICLE
Alicja E Grzegorzewska, Adrianna Mostowska, Wojciech Warchoł, Paweł P Jagodziński
BACKGROUND: To explore associations between PON1 rs854560, rs662, 705,379, HCV clearance, and interactions between tested PON1 single nucleotide variants (SNVs) and interferon-λ4 gene (IFNL4) rs368234815 variant in hemodialyzed individuals. METHODS: The study included 83 HD individuals who spontaneously resolved HCV infection (all had known IFNL4 rs368234815 variant) and 104 individuals with persistently positive blood tests for HCV RNA (102 were IFNL4 rs368234815 variant successfully genotyped)...
August 26, 2021: BMC Infectious Diseases
https://read.qxmd.com/read/34381495/inflammation-and-kidney-involvement-in-human-viral-diseases-caused-by-sars-cov-2-hiv-hcv-and-hbv
#23
REVIEW
Gustavo Ferreira da Mata, Danilo Euclides Fernandes, Eduardo de Paiva Luciano, Gabriel Teixeira Montezuma Sales, Michelle Tiveron Passos Riguetti, Gianna Mastroianni Kirsztajn
Inflammation is closely related to renal diseases. This is particularly true for renal diseases caused by infections as in viral diseases. In this review, we highlight the inflammatory mechanisms that underlie kidney dysfunction in SARS-CoV-2, human immunodeficiency (HIV), hepatitis C (HCV), and hepatitis B (HBV) infections. The pathophysiology of renal involvement in COVID-19 is complex, but kidney damage is frequent, and the prognosis is worse when it happens. Virus-like particles were demonstrated mostly in renal tubular epithelial cells and podocytes, which suggest that SARS-CoV-2 directly affects the kidneys...
2021: Journal of Venomous Animals and Toxins Including Tropical Diseases
https://read.qxmd.com/read/34294065/primary-membranous-glomerulonephritis-with-negative-serum-pla2r-in-haemophilia-a-successfully-managed-with-rituximab-case-report-and-review-of-the-literature
#24
JOURNAL ARTICLE
Nicholas Meyer, Wendy Cooper, Paul Kirwan, Roger Garsia, Scott Dunkley, David M Gracey
BACKGROUND: Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) cause a wide range of glomerular pathologies. In people with haemophilia, transfusion-associated infections with these viruses are common and definitive pathological diagnosis in this population is complicated by the difficulty of safely obtaining a renal biopsy. Membranous nephropathy (MN) is a common cause of adult onset nephrotic syndrome occurring in both primary and secondary forms. Primary MN is associated with podocyte autoantibodies, predominantly against phospholipase A2 receptor (PLA2R)...
July 22, 2021: BMC Nephrology
https://read.qxmd.com/read/34250027/recurrence-of-cryoglobulinemia-secondary-to-hepatitis-c-in-a-patient-with-hcv-rna-negative-in-the-serum
#25
Małgorzata Sikorska-Wiśniewska, Katarzyna Sikorska, Anna Wróblewska, Tomasz Liberek, Agnieszka Perkowska-Ptasińska, Alicja Dębska-Ślizień
Hepatitis C virus infection is associated with many extrahepatic manifestations such as mixed cryoglobulinemia (MC). Renal manifestation of HCV infection might present as cryo-positive membranoproliferative glomerulonephritis (MPGN). First-line therapy includes antiviral treatment as the underlying infection leads to formation of immune complexes. After introducing direct-acting antiviral agents (DAAs) cure rates of HCV infection increased. Sustained virologic response (SVR) is defined as the absence of HCV RNA in serum by a sensitive test performed 12 or 24 weeks after the end of antiviral treatment...
May 2021: Case Reports in Nephrology and Dialysis
https://read.qxmd.com/read/33721396/hepatitis-c-associated-focal-proliferative-glomerulonephritis-in-an-aviremic-recipient-of-a-hepatitis-c-positive-antibody-donor-liver
#26
Humberto Bohorquez, Juan C Q Velez, Mark Lusco, Jennifer Scheuermann, Ari J Cohen
Shortage of organs for liver transplantation (LT) and the availability of highly efficient pan-genotypic direct-acting antivirals (DAAs) against hepatitis C virus (HCV) have allowed the use of livers from HCV-positive antibody/negative nucleic acid test donors (dHCV Ab+/NAT-) into aviremic HCV recipients over the last few years. We report the case of a patient who received an LT from an HCV Ab+/NAT- donor and, after HCV viremic conversion, developed a nephrotic syndrome due to a focal proliferative glomerulonephritis early after LT...
August 2021: American Journal of Transplantation
https://read.qxmd.com/read/33717064/renal-involvement-and-hbv-infection-are-common-in-chinese-patients-with-cryoglobulinemia
#27
JOURNAL ARTICLE
Wei Bai, Lixia Zhang, Jiuliang Zhao, Shangzhu Zhang, Jiaxin Zhou, Xiaomei Leng, Zhengyin Liu, Wenling Ye, Bing Han, Xinping Tian, Mengtao Li, Yan Zhao, Xiaofeng Zeng
Objectives: This study aimed to describe the main characteristics of Chinese patients with cryoglobulinemia, especially the characteristics of patients with different causes of cryoglobulinemia. Methods: Eighty inpatients diagnosed with cryoglobulinemia from different wards in Peking Union Medical College Hospital were included in this study. Demographic, clinical, biological, and renal pathological data were collected. We analyzed the characteristics of 61 patients with different causes of cryoglobulinemia...
2021: Frontiers in Immunology
https://read.qxmd.com/read/33623996/spectrum-of-kidney-diseases-in-patients-with-hepatitis-c-virus-infection
#28
JOURNAL ARTICLE
Shunhua Guo, Meghan E Kapp, Diego M Beltran, Cesar Y Cardona, Dawn J Caster, Ronald R Reichel, Agnes B Fogo
OBJECTIVES: To study the pathologic spectrum of kidney diseases in patients with hepatitis C virus infection (HCV+). METHODS: Native kidney biopsy specimens in HCV+ patients were reviewed. RESULTS: A total of 9,836 native kidney biopsy specimens were evaluated from January 2007 to December 2016, of which 273 (2.8%) were from HCV+ patients, and of these, 115 (42.1%) had diagnoses consistent with HCV-associated glomerulonephritis (GN). Non-HCV-associated kidney diseases comprised most diagnoses (158 cases, 57...
February 24, 2021: American Journal of Clinical Pathology
https://read.qxmd.com/read/33623683/direct-acting-antiviral-therapy-improves-kidney-survival-in-hepatitis-c-virus-associated-cryoglobulinaemia-the-renalcryoglobulinemic-study
#29
JOURNAL ARTICLE
Ana Pérez de José, Javier Carbayo, Anna Pocurull, Teresa Bada-Bosch, Clara Maria Cases Corona, Amir Shabaka, Natàlia Ramos Terrada, Laura Martinez Valenzuela, Ana Huerta, Loreto Fernandez Lorente, Tamara Gelen Malek-Marín, Marian Goicoechea
Background: Direct-acting antiviral agents (DAAs) have shown high rates of sustained virological response in chronic hepatitis C virus (HCV) infection. However, the influence of DAAs on the course of kidney involvement in HCV-associated mixed cryoglobulinaemia (HCV-MC) has been little studied. The aim of this study was to analyse the effects of antiviral treatment on kidney prognosis and evolution in patients diagnosed with HCV-MC. Methods: The RENALCRYOGLOBULINEMIC study is an observational multicentre cohort study of 139 patients with HCV-MC from 14 Spanish centres...
February 2021: Clinical Kidney Journal
https://read.qxmd.com/read/33605311/hepatitis-c-related-membranoproliferative-glomerulonephritis-in-the-era-of-direct-antiviral-agents
#30
JOURNAL ARTICLE
Walid Ahmed Ragab Abdelhamid, Ali Shendi, Mahmoud Zahran, Eman Abd Elbary, Sawsan Fadda
Membranoproliferative glomerulonephritis (MPGN) is the most typical Hepatitis C virus (HCV)-associated glomerulopathy, and the available data about the utilization of direct-acting antivirals (DAA) in HCV-associated glomerulonephritis is inadequate. We evaluated the renal and viral response in two cases of HCV-related MPGN; the first caused by cryoglobulinemia while the second was cryoglobulin-negative. Both patients received immunosuppression besides DAA in different regimens. They achieved partial remission but remained immunosuppression-dependent for more than 6 months after DAA despite sustained virological response, which enabled safer but incomplete immunosuppression withdrawal...
February 12, 2021: Jornal Brasileiro de Nefrologia: ʹorgão Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia
https://read.qxmd.com/read/33595978/hepatitis-c-positive-liver-transplantation-outcomes-and-current-practice
#31
JOURNAL ARTICLE
Christopher J Danford, Joseph S Redman, Diane Alonso
PURPOSE OF REVIEW: The coincidence of the opioid epidemic and the approval of direct-acting antivirals for the treatment of hepatitis C virus (HCV) has resulted in an imbalance in HCV viraemic donors relative to HCV viraemic patients awaiting liver transplantation. Although ethical concerns exist about knowingly infecting patients with HCV in the absence of prospective, protocolized studies, transplantation of HCV-positive liver allografts into HCV-negative recipients has increased exponentially in recent years...
February 11, 2021: Current Opinion in Organ Transplantation
https://read.qxmd.com/read/33583904/immune-thrombocytopenic-purpura-complicated-by-hepatitis-c-virus-related-membranoproliferative-glomerulonephritis-after-rituximab-therapy
#32
JOURNAL ARTICLE
Ai Kubodera, Ayaka Kume, Kiyohito Hayashi, Ryo Shimizu, Akihiro Miyakawa, Yoshihiro Miyauchi, Yoshio Suzuki, Hiroaki Tanaka
We herein report the case of a 54-year-old Japanese man with hepatitis C virus (HCV)-related membranoproliferative glomerulonephritis (MPGN), which developed at the time of relapse of immune thrombocytopenic purpura (ITP) after rituximab therapy. Antiviral therapy for HCV led to the improvement of both MPGN and ITP. Rituximab therapy may have contributed to the exacerbation of HCV infection and induced the development of HCV-related MPGN and the relapse of ITP. Our case suggested that HCV treatment should be prioritized over rituximab therapy for HCV-positive patients with ITP and that antiviral therapy for HCV may be effective for treating ITP itself...
February 15, 2021: Internal Medicine
https://read.qxmd.com/read/33198444/hepatitis-c-virus-related-cryoglobulinemic-vasculitis
#33
REVIEW
Cesare Mazzaro, Endri Mauro, Anna Ermacora, Paolo Doretto, Silvia Fumagalli, Maurizio Tonizzo, Federica Toffolutti, Valter Gattei
INTRODUCTION: Hepatitis C virus (HCV) infection affects about 170 million people worldwide. HCV is responsible for both hepatitis and extra-hepatic manifestations. Chronic infection has been shown to develop in about 70% of cases, and it can progress to cirrhosis or hepatocellular carcinoma. Ten percent of HCV patients may develop extra-hepatic manifestations, including mixed cryoglobulinemia (MC) and non-Hodgkin lymphomas (NHL). Cryoglobulinemic vasculitis (CV) varies, ranging from mild-moderate clinical symptoms (purpura on the legs, asthenia and arthralgias) and chronic hepatitis to severe symptoms (ulcers on the legs, peripheral neuropathy, glomerulonephritis, low-grade NHL to life threatening complications (rapid progressive glomerulonephritis, gastrointestinal vasculitis, acute hyper-viscosity)...
April 2021: Minerva Medica
https://read.qxmd.com/read/33198442/cryoglobulinemic-glomerulonephritis-clinical-presentation-and-histological-features-diagnostic-pitfalls-and-controversies-in-the-management-state-of-the-art-and-the-experience-on-a-large-monocentric-cohort-treated-with-b-cell-depletion-therapy
#34
REVIEW
Daniela Rossi, Savino Sciascia, Roberta Fenoglio, Michela Ferro, Simone Baldovino, Joelle Kamgaing, Federica Ventrella, Ileana Kalikatzaros, Lucia Viziello, Laura Solfietti, Antonella Barreca, Dario Roccatello
Cryoglobulinemia is defined by the presence of immunoglobulins having the following characteristics: forming a gel when temperature is <37 °C, precipitate in a reversible manner in the serum, and redissolve after rewarming. The presence of both polyclonal IgG and monoclonal IgM (type II), or of polyclonal IgG and polyclonal IgM (type III) identifies the mixed cryoglobulinemia (MC). The identification of the Hepatitis C virus (HCV) infection in most of the cases previously defined as "essential" represented a cornerstone in the understanding the pathogenesis of this condition...
April 2021: Minerva Medica
https://read.qxmd.com/read/33119586/schistosoma-mansoni-infection-as-a-trigger-to-collapsing-glomerulopathy-in-a-patient-with-high-risk-apol1-genotype
#35
JOURNAL ARTICLE
Precil D Neves, Ramaiane A Bridi, Janaína A Ramalho, Lectícia B Jorge, Elieser H Watanabe, Andreia Watanabe, Luis Yu, Viktoria Woronik, Rafaela B Pinheiro, Leonardo A Testagrossa, Lívia B Cavalcante, Denise M Malheiros, Cristiane B Dias, Luiz F Onuchic
BACKGROUND: Schistosoma mansoni schistosomiasis (SM) remains a public health problem in Brazil. Renal involvement is classically manifested as a glomerulopathy, most often membranoproliferative glomerulonephritis or focal and segmental glomerulosclerosis. We report a case of collapsing glomerulopathy (CG) associated with SM and high-risk APOL1 genotype (HRG). CASE REPORT: A 35-year-old male was admitted for hypertension and an eight-month history of lower-limb edema, foamy urine, and increased abdominal girth...
October 2020: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/33022028/remission-of-long-term-hepatic-and-renal-disease-induced-by-hcv-after-direct-acting-antivirals-therapy
#36
JOURNAL ARTICLE
Raissa M Arruda, Andrea D Batista, Norma A Filgueira, Izolda F Moura, Luis H Sette, Edmundo P Lopes
In addition to liver disease, the hepatitis C virus (HCV) has been associated with autoimmune phenomena, such as mixed cryoglobulin and glomerulonephritis (GN). Until recently, both chronic hepatitis and HCV extra-hepatic manifestations were treated with peg-interferon plus ribavirin, however these drugs presented low efficacy and induced severe side effects. Nowadays, the HCV chronic hepatitis has been treated with direct acting antivirals (DAA), but studies on the DAA therapy for HCV-associated glomerulonephritis are scarce...
October 5, 2020: Jornal Brasileiro de Nefrologia: ʹorgão Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia
https://read.qxmd.com/read/32999232/the-successful-treatment-of-a-case-of-hcv-associated-cryoglobulinemic-glomerulonephritis-with-rituximab-direct-acting-antiviral-agents-plasmapheresis-and-long-term-steroid-despite-serologically-persistent-cryoglobulinemia
#37
JOURNAL ARTICLE
Koji Muro, Naohiro Toda, Shinya Yamamoto, Motoko Yanagita
Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to improve the clinical outcomes of hepatitis C virus (HCV)-associated cryoglobulinemia in the last decade. Recently, however, persistent cases of cryoglobulinemia have been reported, and the ideal approach to treating such cases has not been established. We herein report a case of the successful treatment of HCV-associated cryoglobulinemic glomerulonephritis with rituximab, DAAs, occasional plasmapheresis and long-term steroid, with the patient's renal function and proteinuria improving over the long term despite serologically persistent cryoglobulinemia...
September 30, 2020: Internal Medicine
https://read.qxmd.com/read/32782479/treatment-of-chronic-hepatitis-c-associated-cryoglobulinemia-vasculitis-at-the-era-of-direct-acting-antivirals
#38
REVIEW
Cloé Comarmond, Patrice Cacoub, David Saadoun
Hepatitis C virus (HCV) infection is responsible for both hepatic and extrahepatic manifestations. Before the era of direct-acting antivirals (DAA), cryoglobulinemia was related to HCV infection in 70-90% of cases. Observed in 30% to 40% of patients with hepatitis C, mixed cryoglobulinemia is mainly asymptomatic. Conversely, symptomatic cryoglobulinemia vasculitis (CV) can occur in 5-10% of patients with HCV-associated cryoglobulinemia. CV is a small-vessel systemic vasculitis, and organ damage results from circulation and precipitation of cryoglobulins and complement activation...
2020: Therapeutic Advances in Gastroenterology
https://read.qxmd.com/read/32676896/renal-pathological-analysis-using-galactose-deficient-iga1-specific-monoclonal-antibody-is-a-strong-tool-for-differentiation-of-primary-iga-nephropathy-from-secondary-iga-nephropathy
#39
JOURNAL ARTICLE
Mingfeng Lee, Hitoshi Suzuki, Rina Kato, Yusuke Fukao, Maiko Nakayama, Toshiki Kano, Yuko Makita, Yusuke Suzuki
In several cases with IgA nephropathy (IgAN), differential diagnosis is difficult due to the complication with other systemic diseases which can induce secondary IgAN. Recently, we demonstrated that immunostaining with galactose-deficient IgA1-specific monoclonal antibody (KM55 mAb) specifically showed positive in primary IgAN cases. Here, we report four cases which we could make definitive diagnosis by immunohistological analysis using KM55 mAb. The underlying systemic diseases are rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), hepatitis C (HCV) and Crohn's disease (CD)...
July 16, 2020: CEN Case Reports
https://read.qxmd.com/read/32334491/cryptococcosis-in-an-hiv-negative-hcv-positive-immunosenescent-patient-a-case-report
#40
JOURNAL ARTICLE
Marta Colaneri, Caterina Cavanna, Marco Mussa, Alessandra Morea, Tommaso Manciulli, Enrico Brunetti, Angela Di Matteo, Fabiola Lallitto
Cryptococcus species is still a very common opportunistic infection in AIDS patients. However, it is increasingly responsible for disease in otherwise immunocompromised individuals, such as transplant recipients and the heterogeneous group of patients with underlying immunologic diseases, hematologic disorders and organ failure syndromes. Clinical presentation, prognosis, and outcomes are difficult to define given these varied host groups, and tailoring treatments to fit the necessities of each patient is likewise challenging...
December 13, 2019: New Microbiologica
keyword
keyword
36705
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.